Frontage Holdings Corporation (HKG:1521)
Hong Kong
· Delayed Price · Currency is HKD 1.120
+0.040 (3.70%)
Mar 10, 2026, 3:35 PM HKT
Frontage Holdings Revenue
Frontage Holdings had revenue of $126.58M USD in the half year ending June 30, 2025, a decrease of -1.39%. This brings the company's revenue in the last twelve months to $253.01M, down -2.68% year-over-year. In the year 2024, Frontage Holdings had annual revenue of $254.91M, down -1.90%.
Revenue (ttm)
$253.01M
Revenue Growth
-2.68%
P/S Ratio
1.14
Revenue / Employee
$164.29K
Employees
1,540
Market Cap
2.27B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clover Biopharmaceuticals | 56.73M |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.43B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 134.60M |
| Jiangsu Recbio Technology | 31.90M |
| Antengene Corporation | 92.43M |
| Zhaoke Ophthalmology | 38.74M |
| SinoMab BioScience | 6.28M |
| Cutia Therapeutics | 274.31M |